WallStreetZenWallStreetZen

NASDAQ: MEDP
Medpace Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Medpace Holdings earnings were $418.3M for the trailing 12 months ending Jun 30, 2025, with 25.4% growth year over year. The latest MEDP earnings report on Jun 30, 2025 announced Q2 2025 earnings of $90.3M, down 21.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MEDP reported annual earnings of $404.4M, with 43% growth. The next MEDP earnings date is Oct 27, 2025.

MEDP past earnings growth

How has MEDP's earnings growth performed historically?

Company
25.41%
Industry
10.51%
Market
34.06%
MEDP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MEDP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MEDP's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MEDP earnings history

Current Revenue
$2.2B
Current Earnings
$418.3M
Current Profit Margin
18.7%

MEDP Return on Equity

Current Company
67.7%
Current Industry
-3.9%
Current Market
30.7%
MEDP's Return on Equity (67.7%)... subscribe to Premium to read more.
High Return on Equity Performance

MEDP undefined

Current Company
21.9%
Current Industry
7.7%
MEDP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MEDP announces earnings.

MEDP undefined

Current Company
136.65%
Current Industry
15.7%
MEDP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MEDP vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MEDP$532.27M$418.30M+36.00%$13.82
ICLR$1.40B$794.25M+10.10%$9.77
ILMN$1.78B$1.26B+10.95%$7.92
EXAS-$731.82M-$1.01BN/A-$5.46
RVTY$799.33M$285.20M-2.29%$2.36
View Top Diagnostic & Research Stocks

MEDP earnings dates

Next earnings date
Oct 27, 2025

Medpace Holdings Earnings Reports & History FAQ

What were Medpace Holdings's earnings last quarter?

On MEDP's earnings call on Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q2 2025 earnings per share (EPS) of $3.16, up 10.88% year over year. Total MEDP earnings for the quarter were $90.26 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $2.85.

If you're new to stock investing, here's how to buy Medpace Holdings stock.

When does Medpace Holdings report earnings?

The next MEDP earnings call is Invalid Date. Add MEDP to your watchlist to be reminded of Medpace Holdings's next earnings date.

Is Medpace Holdings profitable or losing money?

As of the last Medpace Holdings earnings report, Medpace Holdings is currently profitable. Medpace Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $418.30 million, a 23.11% increase year over year.

What was MEDP's earnings growth in the past year?

As of Medpace Holdings's earnings date in Invalid Date, Medpace Holdings's earnings has grown 25.41% year over year. This is 14.9 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.51%. MEDP earnings in the past year totalled $418.30 million.

What are Medpace Holdings's earnings expectations?

The current EPS estimate for Medpace Holdings's earnings report in Invalid Date is $3.47.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.